Label: information for the user
Humalog KwikPen 100 units/mL injectable solution in a pre-filled pen
insulin lispro
Each KwikPen administers 1 to 60 units in increments of 1 unit.
Read the entire label carefully before starting to use this medication, as it contains important information for you.
Humalog KwikPen is used to treat diabetes. It works faster than regular human insulin because the insulin molecule has been slightly changed.
You have diabetes when your pancreas does not produce enough insulin to control your blood glucose level. Humalog is a substitute for your own insulin and is used to control glucose levels in the long term. It acts very quickly and for a shorter time than soluble insulin (2 to 5 hours). Humalog is usually used within 15 minutes of eating.
Your doctor may recommend using Humalog KwikPen in addition to a longer-acting insulin. Each one comes with its own leaflet with specific information. Do not change your insulin unless your doctor tells you to. Be very careful when changing insulin.
The use of Humalog is suitable for adults and children.
The KwikPen is a pre-filled disposable pen that contains 3 ml (300 units, 100 units/ml) of insulin lispro. A KwikPen contains multiple doses of insulin. The KwikPen marks 1 unit each time.
The number of units is shown in the dosing window, check it always before your injection.
You can inject from 1 to 60 units in a single injection.
If your dose is more than 60 units, you will need to administer more than one injection.
Do not use Humalog KwikPen
Warnings and precautions
Inform your doctor as soon as possible if you have signs of heart failure such as difficulty breathing, rapid weight gain, or localized inflammation (edema).
Changes in skin at the injection site
The injection site should be rotated to avoid changes in the skin, such as lumps under the skin. Insulin may not work well if injected into a swollen area (see How to use Humalog KwikPen). Please contact your doctor if you are currently injecting into a swollen area, before starting to inject into a different area. Your doctor may instruct you to check your blood sugar levels more closely, and adjust the insulin or the dose of your other diabetes medications.
Other medicines and Humalog KwikPen
Your insulin needs may change if
Inform your doctor if you are using, have used recently, or may need to use any other medicine, even those purchased without a prescription (see Section “Warnings and precautions”).
Pregnancy and breastfeeding
Are you pregnant or planning to become pregnant? Are you breastfeeding? The amount of insulin you need usually decreases during the first three months of pregnancy and increases during the next six months. If you are breastfeeding, you may need to adjust the dose of insulin or your diet. If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medicine.
Driving and operating machinery
Your ability to concentrate or react may be reduced if you experience hypoglycemia. Be aware of this possible problem, considering all situations that may pose a risk to you or others (e.g. driving a vehicle or operating machinery). You should consult your doctor about the advisability of driving if you have:
Humalog KwikPen contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per dose; it is essentially “sodium-free”.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor again. To prevent the possible transmission of diseases, each pen must be used only by you, even if the needle is changed.
Dose
How to prepare Humalog KwikPen
How to prepare the KwikPen (please read the user manual)
How to inject Humalog
After the injection
Subsequent injections
Use of Humalog in an insulin infusion pump
If you use more Humalog than you should
If you use more Humalog than you need or are unsure of how much you have injected, you may have low blood sugar. Check your blood sugar.
If your blood sugar is low(mild hypoglycemia), take glucose tablets, sugar, or a sweet drink. Then eat fruit, cookies, or a snack, as your doctor has instructed, and rest afterwards. This usually helps to overcome mild hypoglycemia or a small overdose of insulin. If you get worse and your breathing is shallow and your skin is pale, call your doctor immediately. Severe hypoglycemia can be treated with glucagon injection. After glucagon injection, take glucose or sugar. If you do not respond to glucagon, you should go to the hospital. Ask your doctor to inform you about glucagon.
If you forget to use Humalog
If you use less Humalog than you need or are unsure of how much you have injected, you may have high blood sugar. Check your blood sugar.
If not treated properly, hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar) can be very serious and cause headaches, nausea, vomiting, dehydration, loss of consciousness, coma, and even death (see A and B in section 4 "Possible side effects").
Three simple measuresto avoid hypoglycemia or hyperglycemia are:
If you interrupt Humalog treatment
If you use less Humalog than you need, you may have high blood sugar. Do not change insulin unless your doctor tells you to.
If you have any other questions about using this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Systemic allergy is rare (≥1/10,000 to <1
|
|
|
|
|
|
If you think you are experiencing this type of allergy with Humalog, speak immediately with your doctor.
Localized allergy is common (≥ 1/100 to <1
Lipodystrophy is infrequent (≥ 1/1,000 to <1and (cutaneous amyloidosis). Insulin may not work well if injected into a swollen area. Change the injection site to help prevent these skin changes.
Cases of edema (e.g. swelling in the arms, legs; fluid retention) have been reported, especially at the beginning of insulin treatment or during a change in treatment to improve blood sugar control.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through thenational notification system included in theAppendix V. By reporting side effects, you can contribute to providing more information about the safety of this medicine.
Common problems of diabetes
Hypoglycemia (low blood sugar) means that you do not have enough sugar in your blood. It can be caused by:
Alcohol and certain medications can affect your blood sugar levels.
The first symptoms of low blood sugar usually appear suddenly and are accompanied by:
|
|
|
|
|
|
Until you are sure of recognizing the alarm symptoms, avoid situations (e.g. driving a car) in which you or others may be put in danger if hypoglycemia occurs.
Hyperglycemia (high blood sugar) means that the body does not have enough insulin. Hyperglycemia can be caused by:
Hyperglycemia can lead to diabetic ketoacidosis. The first symptoms appear slowly,over many hours or several days. Among these symptoms are the following:
|
|
|
|
|
|
Severe symptoms are deep breathing and rapid pulse.Get medical help immediately.
If you are ill, especially if you have nausea or vomiting, the amount of insulin you need may vary.Although you may not be eating as usual, you still need to receive insulin.Get urine or blood tests, follow the instructions you have been given for when you are ill, and call your doctor.
Before first use, store Humalog KwikPen in the refrigerator (between 2°C and 8°C). Do not freeze.
Store your Humalog KwikPen in use at room temperature (below 30°C) and discard after 28 days. Do not leave it near any heat source or in the sun. Do not store the KwikPen in use in the refrigerator. The KwikPen should not be stored with the needle attached.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the label and on the packaging. The expiration date is the last day of the month indicated.
Do not use this medication if you observe that it has changed color or if it contains solid particles. It should only be used if its appearance is like that of water. Check this before each injection.
Medications should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the packaging and medications that you no longer need. This will help protect the environment.
Composition of Humalog KwikPen 100 units/mL injectable solution
Appearance of the product and contents of the package
Humalog KwikPen 100 units/mL injectable solution is a sterile, transparent, colorless, aqueous solution containing 100 units of insulin lispro in each milliliter of injectable solution (100 units/mL). Each Humalog KwikPen contains 300 units (3 milliliters). Humalog KwikPen is presented in a package of 5 pre-filled pens or in a multiple package consisting of 2 packages of 5 pre-filled pens. Not all presentations may be marketed. The Humalog 100 units/mL contained in your pre-filled pen is the same as the Humalog 100 units/mL presented in Humalog 100 units/mL cartridges. The KwikPen simply contains a cartridge inside. When the pre-filled pen is empty, it cannot be reused.
Holder of the marketing authorization and responsible manufacturer
Humalog KwikPen 100 units/mL injectable solution is manufactured by:
The holder of the marketing authorization is Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, Netherlands.
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Belgium/België/Belgien Eli Lilly Benelux S.A./N.V. Tel: + 32-(0)2 548 84 84 | Lithuania Eli Lilly Lietuva Tel: +370 (5) 2649600 |
Luxembourg/Luxemburg Eli Lilly Benelux S.A./N.V. Tel: + 32-(0)2 548 84 84 | |
Czech Republic ELI LILLY CR, s.r.o. Tel: + 420 234 664 111 | Hungary Lilly Hungária Kft. Tel: + 36 1 328 5100 |
Denmark Eli Lilly Danmark A/S Tel: +45 45 26 6000 | Malta Charles de Giorgio Ltd. Tel: + 356 25600 500 |
Germany Lilly Deutschland GmbH Tel: +49-(0) 6172 273 2222 | Netherlands Eli Lilly Nederland B.V. Tel: + 31-(0) 30 60 25 800 |
Estonia Eli Lilly Nederland B.V. Tel: +372 6817 280 | Norway Eli Lilly Norge A.S. Tel: + 47 22 88 18 00 |
Greece ΦΑΡΜΑΣΕΡΒ-ΛΙΛΛΥ Α.Ε.Β.Ε. Tel: +30 210 629 4600 | Austria Eli Lilly Ges. m.b.H. Tel: + 43-(0) 1 711 780 |
Spain Lilly S.A. Tel: + 34-91 663 50 00 | Poland Eli Lilly Polska Sp. z o.o. Tel: +48 22 440 33 00 |
France Lilly France Tel: +33-(0) 1 55 49 34 34 | Portugal Lilly Portugal - Produtos Farmacêuticos, Lda Tel: + 351-21-4126600 |
Croatia Eli Lilly Hrvatska d.o.o. Tel: +385 1 2350 999 | Romania Eli Lilly România S.R.L. Tel: + 40 21 4023000 |
Ireland Eli Lilly and Company (Ireland) Limited Tel: + 353-(0) 1 661 4377 | Slovenia Eli Lilly farmacevtska družba, d.o.o. Tel: +386 (0) 1 580 00 10 |
Iceland Icepharma hf. Tel: + 354 540 8000 | Slovakia Eli Lilly Slovakia s.r.o. Tel: + 421 220 663 111 |
Italy Eli Lilly Italia S.p.A. Tel: + 39- 055 42571 | Finland Oy Eli Lilly Finland Ab Tel: + 358-(0) 9 85 45 250 |
Cyprus Phadisco Ltd Tel: +357 22 715000 | Sweden Eli Lilly Sweden AB Tel: + 46-(0) 8 7378800 |
Lithuania Eli Lilly (Suisse) S.A Parstavnieciba Latvija Tel: +371 67364000 | United Kingdom (Northern Ireland) Eli Lilly and Company (Ireland) Limited Tel: + 353-(0) 1 661 4377 |
Last review date of this leaflet:
USER MANUAL
The user manual text is included at the end.
More detailed information about this medicine is available on the website of the European Medicines Agency:http://www.ema.europa.eu.
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.